Toritz T 500 mg Injection
$418,70
$326,60
Toritz T 500 mg Injection is a targeted monoclonal antibody therapy designed to combat various immune-related disorders, particularly specific types of cancer such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By selectively binding to cancerous cells, this medication helps to inhibit their growth and promotes the body’s natural immune response to eliminate these abnormal cells. Administered through injection, Toritz T offers a crucial treatment option for patients facing these serious health challenges. It is important for patients to discuss potential side effects and contraindications with their healthcare provider, as this drug may not be suitable for everyone. Regular monitoring is advised to ensure optimal outcomes while minimizing risks. With its innovative approach, Toritz T represents a significant advancement in the field of oncology, providing hope and improved quality of life for many patients. Always consult a medical professional for personalized advice regarding this therapy to understand its full benefits and risks.
數量
Active Pharmaceutical Ingredient
Uses
• Toritz t 500 mg injection is commonly used in the treatment of Non-Hodgkin lymphoma (NHL). This medication helps to manage the abnormal growth of lymphatic cells associated with NHL. By targeting these cells, Toritz t 500 mg injection can assist in reducing tumor size and improving patient outcomes. Healthcare providers often choose this treatment for its effectiveness in controlling the disease.
• Another important use of Toritz t 500 mg injection is in the management of rheumatoid arthritis. This condition is characterized by chronic inflammation of the joints, leading to pain and disability. Toritz t 500 mg injection works by modulating the immune response, which helps to alleviate symptoms and improve joint function. Patients may receive this injection as part of a comprehensive treatment plan.
• Toritz t 500 mg injection is also indicated for blood cancers, specifically chronic lymphocytic leukaemia (CLL). This medication aids in targeting the cancerous cells that proliferate in CLL, helping to slow the progression of the disease. The administration of Toritz t 500 mg injection can enhance the quality of life for those affected by this condition. It is often utilized alongside other therapeutic strategies for optimal results.
• In cases of granulomatosis with polyangiitis and microscopic polyangiitis, Toritz t 500 mg injection can play a critical role in treatment. These conditions involve inflammation of blood vessels, leading to various systemic complications. Toritz t 500 mg injection helps to reduce this inflammation, thereby improving overall patient health and functionality. Physicians may recommend this injection to effectively manage symptoms and prevent further complications.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Toritz T 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Toritz T 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Toritz T 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Toritz T 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Toritz T 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Toritz T 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Toritz T 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Toritz T 500 mg. Please consult your doctor.
• Kidney: Toritz T 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Toritz T 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Toritz T 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Toritz T 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Toritz T 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.